Strategy Shares Newfound/ReSolve Robust Momentum ETF
ROMO · ETF
About ROMO
- Issuer
- Strategy Shares
- Tracks
- Newfound/ReSolve Robust Equity Momentum Index
- Expense ratio
- 0.92%
- Assets under management
- $25.65M
- Inception
- Nov 1, 2019
- Asset class
- Asset Allocation
- Website
- strategysharesetfs.com
ROMO key statistics
- Market cap
- 0
- Price-earnings ratio
- 0.00
- Average volume
- 2.15K
- Volume
- 86
- Open price
- $33.82
- High today
- $33.62
- Low today
- $33.62
- 52 Week high
- $35.13
- 52 Week low
- $30.46
Strategy Shares Newfound/ReSolve Robust Momentum ETF (ROMO) at a glance
Strategy Shares Newfound/ReSolve Robust Momentum ETF (ROMO) last traded at $33.62, with a market cap of 0 and a price-to-earnings ratio of 0.00.
Volume so far is 86 shares, below the average of 2.15K shares a day.
Over the past year Strategy Shares Newfound/ReSolve Robust Momentum ETF has ranged from $30.46 to $35.13, and now sits 68% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.